A course of oral antiviral medication following infection with the herpes simplex virus (HSV) may help to reduce the risk of recurring eye-related manifestations of the disease, a new report claims.
According to a recent study in an issue of Archives of Ophthalmology, one of the JAMA/Archives journals, HSV sufferers who were not given oral antiviral therapy were 9.4 times more likely to have a recurrence of epithelial keratitis.
In addition, they were 8.4 times more likely to have a recurrence of stromal keratitis and 34.5 times more likely to have a recurrence of blepharitis.
Dr Ryan Young, from the Mayo Clinic in Rochester, Minnesota, and colleagues estimated the incidence of HSV eye disease in a community-based cohort, in Olmstead County, Minnesota.
He noted: "The results of this study suggest that oral antiviral prophylaxis should be considered for patients with frequent recurrences of corneal disease."
It comes after a study by experts at Duke University Medical Center found that a new type of gene therapy may be effective for people suffering from myopia.
by Martin Burns